Advanced search×

Multidisciplinary approach for prescriptive management of mineral and bone metabolism in chronic kidney disease: development of a dietetic led protocol.

Jonathan Casey, Chui Han Li, V Johnsson, C Sluman, and P McClelland

J Ren Care 32(4):187-91 (2006) PMID 17345976

A number of mineral metabolism abnormalities occur as kidney function declines, these include hyperphosphatemia, hyperparathyroidism and altered vitamin D metabolism. These derangements are associated with increased morbidity and mortality amongst the chronic kidney disease patient group. Treatment requires a multidisciplinary team approach in which the dietitian plays a pivotal role.

Version: za2963e q8za5 q8zb0 q8zce q8zdc q8ze0 q8zf5 q8zg8
Buy PDF

Similar articles you may find interesting…

  1. Trends in the medical management of patients with heart failure.
    Samuel W Joffe, Matthew Dewolf, and Robert J Goldberg

    J Clin Med Res 5(3):194-204 (2013) PMID 23671545

    We reviewed the medical records of 9,748 residents of the Worcester, MA, metropolitan area who were hospitalized with ADHF at all 11 central Massachusetts medical centers in 1995, 2000, 2002, and 2004. Between 1995 and 2004, respectively, the prescription upon hospital discharge of b...
    PDF not found
  2. Cardiovascular Event Rates in Atorvastatin Patients Versus Simvastatin-Switching Patients.
    Terry A Jacobson, Debra A Wertz, and Mark Cziraky

    Curr Med Res Opin (2013) PMID 23647370

    Total of 73,960 atorvastatin/7,396 simvastatin-switch patients were analyzed. Mean age was 54±7 years (both cohorts). Mean follow-up was 440 days for atorvastatin/237 days for simvastatin-switch. Mean dose and therapy duration for atorvastatin was 20mg and 321 days compared with 33mg and 195 days f...
    Buy PDF
  3. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
    Emma Yue Zhang, Massimo Cristofanilli, and William S Hancock

    J Proteome Res (2013) PMID 23647160

    We selected three breast cancer cell lines (SKBR3, SUM149 and SUM190) with different oncogene expression levels involved in ERBB2 and EGFR signaling pathways as a model system for the evaluation of selective integration of subsets of transcriptomic and proteomic data. We assessed the oncogene status...
    Buy PDF